The Centers for Disease Control and Prevention (CDC) said Thursday that the salmonella outbreak that began in April across the country appears to be over and it's now safe to eat raw jalapeno or serrano peppers grown, harvested, or packed in Mexico.

The U.S. Food and Drug Administration (FDA) has lifted its advice to consumers to avoid eating jalapeńo and serrano peppers grown, harvested or packed in Mexico

The new U.S. Food and Drug Administration law permitting the use of irradiation on spinach and iceberg lettuce will take some time before it will be practiced widely across the country.

According to David Gombas, senior vice president of the United Fresh Produce Association, the slow adoption to the technique is due to its cost, lack of irradiation facilities, questions over its effectiveness and consumer response to produce zapped by radiation waves

The makers of the type 2 diabetes drug Byetta reported Tuesday the deaths of four more people who'd been taking the medication bringing the total to six.

Last week, Eli Lilly & Co. and Amylin Pharmaceuticals Inc.'s diabetes drug Byetta was linked to two deaths and four hospitalizations. All the patients are reported to have died after developing acute pancreatitis, the manufacturer said. The condition can cause nausea, vomiting and abdominal pain

The U.S. Food and Drug Administration (FDA) on Wednesday allowed XDx Inc. to sell a test for heart-transplant patients. The drug will save the transplant patients from repeated biopsies to check if their bodies are rejecting the new organ.

Currently, transplant patients have to get tissue samples from the heart checked to look for signs if their body is rejecting the organ. Such procedures can be hard to perform and risky for the patient. The new non-invasive test will save them from this ordeal

The U.S. Food and Drug Administration (FDA) on Thursday said it is investigating reports that link cholesterol-lowering drug Vytorin to an increased risk of cancer.

Though the data from two large, ongoing trials involving ezetimibe/simvastatin (Vytorin) show no increased risk of cancer, the FDA is reviewing a recent study, called SEAS (Simvastatin and Ezeimibe in Aortic Stenosis), which found an increased risk of cancer and deaths from cancer in patients taking the drug